Rivus Pharmaceuticals

Headquarters
Charlottesville
Employees
11–50
Business Model
B2B

About

Rivus Pharmaceuticals is a clinical-stage biopharmaceutical company dedicated to transforming the treatment of cardio-metabolic disease. Its first-in-class small molecule therapy, HU6, is a Controlled Metabolic Accelerator (CMA) that activates mitochondrial uncoupling to address the underlying cause of conditions including type 2 diabetes, hypertension, NASH, and obesity. The company has advanced HU6 through multiple Phase 2 clinical trials and is backed by investors including Medicxi, Longitude Capital, RA Capital Management, and Bain Capital Life Sciences.

Summary

Rivus Pharmaceuticals is a Biotech company based in Charlottesville, United States.

Similar Companies